Drug profile

The FDA adverse-event record for Felv Gp70 Carbomer Adj Kv

38 adverse-event reports submitted to the FDA Center for Veterinary Medicine reference Felv Gp70 Carbomer Adj Kv. Species, reactions, and outcomes follow.

#1287 of 2,679
by report volume (all drugs)
38
adverse-event reports
15.8%
death-coded share
Cat
most-reported species
Verify with FDA CVM →

Corpus placement

According to the FDA Center for Veterinary Medicine openFDA adverse-event extract, Felv Gp70 Carbomer Adj Kv ranks #1283 of 2679 by total reports (38). Death-coded-share rank requires at least 50 reports. National dual: Milbemycin Oxime + Spinosad is #1 of 2679 drugs by total adverse-event reports (149,624) at death-coded-share rank 965 of 1130 drugs with at least 50 reports (2.3%); separately, Atlantic Salmon Transgenic Whole (Opafp-Ghc2 Rdna Construct Inserted Into The A-Locus In The Eo-1A Lineage) is #1 highest death-coded share at 97.8% (report rank #821).

149,624
Milbemycin Oxime + Spinosad reports (#1)
97.8%
Atlantic Salmon Transgenic Whole (Opafp-Ghc2 Rdna Construct Inserted Into The A-Locus In The Eo-1A Lineage) death share (#1)
#1283
This drug, reports of 2679

Report volume reflects how common a breed or drug is and how often owners and vets file — not actual risk. Death-coded share ranks are limited to entries with enough reports to be meaningful. The two maps do not agree at #1.

Release-over-release change

What changed in the latest FDA data snapshot

PlainBreed reconstructed the prior snapshot from dated openFDA partitions through 2025 Q4, then compared it with the 2026-07-27 openFDA export. Felv Gp70 Carbomer Adj Kv has 38 reports now versus 36 in that prior snapshot: 2 more (5.6%).

Report change
+2
Death-coded reports
+1
Death-coded share
+1.9 pts

This compares reported-event counts in two source snapshots. It does not establish a change in real-world risk, product safety, or disease incidence.

Subscribe to Felv Gp70 Carbomer Adj Kv changes

Signature read: death-coded share at 15.8% is the most distinctive stamp on Felv Gp70 Carbomer Adj Kv's FDA AER row.

Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
38
Total Reports
6
Deaths Reported
15.8%
Death-coded share of reports

Active Ingredients

Felv Gp70 Carbomer Adj Kv

Administration Routes

Subcutaneous

Species Affected

Cat 38

Most Affected Breeds

Domestic Shorthair 30
Domestic Mediumhair 5
Maine Coon 1
Scottish Fold Shorthair 1
American Shorthair 1

Most Reported Reactions

Lethargy (see also Central nervous system depression in 'Neurological') 11
Emesis (multiple) 9
Fever 6
Ataxia 5
Not eating 5
Application site hair loss 5
Vomiting 4
Stumbling gait 4
Application site scab 4
Anorexia 3
Dilated pupils 3
Vocalisation 3

Outcome Breakdown

Ongoing
17 (44.7%)
Recovered/Normal
10 (26.3%)
Died
4 (10.5%)
Outcome Unknown
3 (7.9%)
Euthanized
2 (5.3%)
Recovered with Sequela
2 (5.3%)

Felv Gp70 Carbomer Adj Kv Adverse Event Insights

Read these counts as reporting volume, not risk: per our methodology, a widely-prescribed drug will rack up more raw FDA reports in a given year than a rarely-used one at an identical true rate, so we recommend comparing within similar-exposure products rather than across the full 2025 catalog.

What to do with this drug

A report does not prove a drug caused the reaction; consult a veterinarian before acting on this data.

Source: FDA Center for Veterinary Medicine openFDA Animal & Veterinary Adverse Events (CVM AER) · 2025

openFDA Animal & Veterinary Adverse Events (FDA CVM) for Felv Gp70 Carbomer Adj Kv (#1287 of 2,679 by report volume); death-coded 15.8%. PlainBreed drug row · death-coded share stamp 15.8% · vintage 2025.

Informational only. FDA adverse-event reports are voluntary and do not prove causation; consult a veterinarian before acting on them. Verify with FDA CVM →